BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38490918)

  • 1. Neurodevelopmental outcomes of extremely preterm infants with bronchopulmonary dysplasia (BPD) - A retrospective cohort study.
    Nguyen KL; Fitzgerald DA; Webb A; Bajuk B; Popat H
    Paediatr Respir Rev; 2024 Jun; 50():23-30. PubMed ID: 38490918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study.
    Thomas SR; Jain SK; Murthy P; Joseph CJ; Soraisham A; Tang S; Dosani A; Lodha A
    Am J Perinatol; 2024 May; 41(S 01):e2505-e2513. PubMed ID: 37399847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental outcomes of extremely preterm infants in New South Wales and the Australian Capital Territory.
    Bolisetty S; Tiwari M; Sutton L; Schindler T; Bajuk B; Lui K;
    J Paediatr Child Health; 2019 Aug; 55(8):956-961. PubMed ID: 30499234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
    Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with neurodevelopmental impairment in preterm infants with bronchopulmonary dysplasia.
    Yazici A; Buyuktiryaki M; Simsek GK; Kanmaz Kutman HG; Canpolat FE
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(5):1579-1585. PubMed ID: 35302203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.
    Bell EF; Hintz SR; Hansen NI; Bann CM; Wyckoff MH; DeMauro SB; Walsh MC; Vohr BR; Stoll BJ; Carlo WA; Van Meurs KP; Rysavy MA; Patel RM; Merhar SL; Sánchez PJ; Laptook AR; Hibbs AM; Cotten CM; D'Angio CT; Winter S; Fuller J; Das A;
    JAMA; 2022 Jan; 327(3):248-263. PubMed ID: 35040888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia.
    Gallini F; Coppola M; De Rose DU; Maggio L; Arena R; Romano V; Cota F; Ricci D; Romeo DM; Mercuri EM; Vento G
    Early Hum Dev; 2021 Jan; 152():105275. PubMed ID: 33227635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of mechanical ventilation and prediction of bronchopulmonary dysplasia and home oxygen in extremely preterm infants.
    Dassios T; Williams EE; Hickey A; Greenough A
    Acta Paediatr; 2021 Jul; 110(7):2052-2058. PubMed ID: 33555069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between bronchopulmonary dysplasia grade and risks of adverse neurodevelopmental outcomes among preterm infants born at less than 30 weeks of gestation.
    Oluwole I; Tan JBC; DeSouza S; Hutchinson M; Leigh RM; Cha M; Rodriguez A; Hou G; Rao SS; Narang A; Chou FS
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2167074. PubMed ID: 36642443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Neurodevelopmental Impairment at 2- and 5-Years Corrected Age in Preterm Infants with Established Bronchopulmonary Dysplasia.
    Katz TA; van Kaam AH; Mugie SM; Aarnoudse-Moens CSH; de Groof F; van Kempen AAMW; van den Heuvel MEN; Vogelzang J; Rijpert M; Schiering IA; Koomen-Botman I; Visser F; Leemhuis AG; Onland W
    Neonatology; 2024; 121(1):125-132. PubMed ID: 37852207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Bronchopulmonary Dysplasia Among Extremely Preterm Infants in Japan, 2003-2016.
    Nakashima T; Inoue H; Sakemi Y; Ochiai M; Yamashita H; Ohga S;
    J Pediatr; 2021 Mar; 230():119-125.e7. PubMed ID: 33246013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study.
    Nakanishi H; Uchiyama A; Kusuda S
    J Perinatol; 2016 Oct; 36(10):890-6. PubMed ID: 27442157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental impairment at 2 years of age in children born before 29 weeks' gestation with bronchopulmonary dysplasia.
    Decollogne L; Epiard C; Chevallier M; Ego A; Alin L; Debillon T
    Arch Pediatr; 2021 Jan; 28(1):23-28. PubMed ID: 33257210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchopulmonary dysplasia in very preterm infants: Outcome up to preschool age, in a single center of Austria.
    Reiterer F; Scheuchenegger A; Resch B; Maurer-Fellbaum U; Avian A; Urlesberger B
    Pediatr Int; 2019 Apr; 61(4):381-387. PubMed ID: 30793436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
    Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted Ventilation Associated with Reduced Neurodevelopmental Impairment in Preterm Infants.
    Vliegenthart RJS; Onland W; van Wassenaer-Leemhuis AG; De Jaegere APM; Aarnoudse-Moens CSH; van Kaam AH
    Neonatology; 2017; 112(2):172-179. PubMed ID: 28601870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-life respiratory trajectories and neurodevelopmental outcomes in infants born very and extremely preterm: A retrospective study.
    Yu WH; Chu CH; Lin YC; Chen RB; Iwata O; Huang CC
    Dev Med Child Neurol; 2022 Oct; 64(10):1246-1253. PubMed ID: 35383902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.